← Back to Patent Explorer
US4476114A Expired / Lapsed US ⏱️ 0.0 years remaining

Iron-selenium preparation

Assignee: Orion Oyj
•
Filing: 1983-04-05
•
Granted: 1984-10-09
•
Expires: 2003-04-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A composition is provided for the treatment of deficiency state of iron and selenium in a mammal, which composition comprises a precipitate-free solution containing a deficiency-treating amount of an iron compound and a selenium compound, wherein the iron compound is ferric dextran, ferric polymaltose or the corresponding hydrolysates thereof, and the selenium compound is selenium dioxide or selenium selenite.

Inventors

  • 👤 Timo J. Pekkanen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 19:36
CPC Classifications
A; A61; A61K; A61K33/00; A61K33/04; A61K33/24; A61K33/26

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 61 words
An injectable trace element solution comprising a precipitate-free aqueous solution containing a deficiency-treating amount of an iron compound and a selenium compound, wherein the iron compound is ferric dextran, ferric polymaltose or the corresponding hydrolysates thereof, and the selenium compound is selenium dioxide or sodium selenite, the ratio of selenium to iron being from 10 -5 to 10 -1 by weight.
Claim 2
Dependent Claim 61 words
An injectable trace element solution comprising a precipitate-free aqueous solution containing a deficiency-treating amount of an iron compound and a selenium compound, wherein the iron compound is ferric dextran, ferric polymaltose or the corresponding hydrolysates thereof, and the selenium compound is selenium dioxide or sodium selenite, the ratio of selenium to iron being from 10 -5 to 10 -1 by weight.
Claim 3
Dependent Claim 12 words
The solution of claim 1 wherein the selenium compound is sodium selenite.
Claim 4
Dependent Claim 16 words
The solution of claim 1 wherein the iron compound is ferric dextran or the corresponding hydrolysate.
Claim 5
Dependent Claim 21 words
The solution of claim 1 wherein the ratio of selenium to iron is from 10 -3 to 10 -2 by weight.
Claim 6
Dependent Claim 28 words
A method of treating a deficiency state of iron and selenium in a mammal comprising administering to the mammal a deficiency-treating amount of the solution of claim 1.

References Cited (Backward Citations)

US2820740A Cited
US3022221A Cited
US3076798A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-10-09 1988-04-09 1988-10-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-10-09 1992-04-09 1992-10-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-10-09 1996-04-09 1996-10-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag